Anti-leukemic effects investigation of alpha-mangostin: apoptotic induction and synergistic potential with chemotherapeutic drugs, molecular targets in leukemic cell lines and bone marrow-derived acute leukemic cells

Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) remain challenging to treat because of treatment-related toxicity, drug resistance, and disease relapse. Alpha-mangostin, a xanthone derivative from Garcinia mangostana , has demonstrated anticancer and pro-apoptotic activities in several experimental models. This study investigated the cytotoxic and apoptosis-associated effects of alpha-mangostin in acute leukemic cells and its interaction with daunorubicin. Cytotoxicity was assessed by MTT assay in NB-4 and MOLT-4 cell lines and normal peripheral blood mononuclear cells. Drug interactions with daunorubicin were evaluated using the Chou-Talalay combination index method. Apoptosis was assessed by Annexin V/PI flow cytometry in leukemic cell lines and patient-derived bone marrow leukemic cells. Predicted protein associations were explored using STITCH. Expression of PARP1 , caspase-3 , caspase-8 , and caspase-9 was evaluated by RT-qPCR, and PARP1 and caspase-3 cleavage by western blotting. Statistical analyses were performed using unpaired two-tailed Student’s t-tests or one-way ANOVA followed by Sidak’s multiple-comparisons test. Alpha-mangostin showed dose- and time-dependent cytotoxicity, with IC 50 values of 37.21 and 35.61 µM at 24 h and 18.76 and 19.67 µM at 48 h in NB-4 and MOLT-4 cells, respectively. At 48 h, selectivity indices were 1.77 and 1.69, respectively. At the IC 50 combination, combination index values were 0.89–0.92 in NB-4 and 0.81 in MOLT-4, whereas values at the half-IC 50 combination were > 1. Alpha-mangostin increased total apoptosis to 43.17 ± 2.45% in NB-4 and 40.00 ± 5.79% in MOLT-4 cells. In patient-derived cells, total apoptosis was 22.58 ± 2.80% in AML and 21.46 ± 3.29% in ALL samples. Alpha-mangostin treatment was also associated with increased expression of apoptosis-related genes and increased cleavage of PARP1 and caspase-3. Alpha-mangostin exhibited cytotoxic and pro-apoptotic activity in acute leukemic cell lines and patient-derived leukemic cells. Its interaction with daunorubicin was concentration-dependent, with combination index values below 1 at the IC 50 combination but not at the half-IC 50 combination. The modest selectivity indicates a limited in vitro therapeutic window. Further mechanistic and in vivo studies are warranted to determine its therapeutic relevance in acute leukemia.

Authors

Institutions

Publication Details

Journal
BMC Complementary Medicine and Therapies
Published
2026-11-13
DOI
https://doi.org/10.1186/s12906-026-05669-9
Primary Topic
Natural Compound Pharmacology Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Anti-leukemic effects investigation of alpha-mangostin: apoptotic induction and synergistic potential with chemotherapeutic drugs, molecular targets in leukemic cell lines and bone marrow-derived acute leukemic cells

Wasinee Kheansaard, Dalina I. Tanyong, Weerapat Owattanapanich, Attasak Jaree et al.
BMC Complementary Medicine and Therapies
Natural Compound Pharmacology Studies
article

Anti-leukemic effects investigation of alpha-mangostin: apoptotic induction and synergistic potential with chemotherapeutic drugs, molecular targets in leukemic cell lines and bone marrow-derived acute leukemic cells

Wasinee Kheansaard, Dalina I. Tanyong, Weerapat Owattanapanich, Attasak Jaree, Chutiphong Jirawatpraphakorn
article en

Abstract

Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) remain challenging to treat because of treatment-related toxicity, drug resistance, and disease relapse. Alpha-mangostin, a xanthone derivative from Garcinia mangostana , has demonstrated anticancer and pro-apoptotic activities in several experimental models. This study investigated the cytotoxic and apoptosis-associated effects of alpha-mangostin in acute leukemic cells and its interaction with daunorubicin. Cytotoxicity was assessed by MTT assay in NB-4 and MOLT-4 cell lines and normal peripheral blood mononuclear cells. Drug interactions with daunorubicin were evaluated using the Chou-Talalay combination index method. Apoptosis was assessed by Annexin V/PI flow cytometry in leukemic cell lines and patient-derived bone marrow leukemic cells. Predicted protein associations were explored using STITCH. Expression of PARP1 , caspase-3 , caspase-8 , and caspase-9 was evaluated by RT-qPCR, and PARP1 and caspase-3 cleavage by western blotting. Statistical analyses were performed using unpaired two-tailed Student’s t-tests or one-way ANOVA followed by Sidak’s multiple-comparisons test. Alpha-mangostin showed dose- and time-dependent cytotoxicity, with IC 50 values of 37.21 and 35.61 µM at 24 h and 18.76 and 19.67 µM at 48 h in NB-4 and MOLT-4 cells, respectively. At 48 h, selectivity indices were 1.77 and 1.69, respectively. At the IC 50 combination, combination index values were 0.89–0.92 in NB-4 and 0.81 in MOLT-4, whereas values at the half-IC 50 combination were > 1. Alpha-mangostin increased total apoptosis to 43.17 ± 2.45% in NB-4 and 40.00 ± 5.79% in MOLT-4 cells. In patient-derived cells, total apoptosis was 22.58 ± 2.80% in AML and 21.46 ± 3.29% in ALL samples. Alpha-mangostin treatment was also associated with increased expression of apoptosis-related genes and increased cleavage of PARP1 and caspase-3. Alpha-mangostin exhibited cytotoxic and pro-apoptotic activity in acute leukemic cell lines and patient-derived leukemic cells. Its interaction with daunorubicin was concentration-dependent, with combination index values below 1 at the IC 50 combination but not at the half-IC 50 combination. The modest selectivity indicates a limited in vitro therapeutic window. Further mechanistic and in vivo studies are warranted to determine its therapeutic relevance in acute leukemia.

BMC Complementary Medicine and Therapies
Siriraj Hospital (TH), Kasetsart University (TH), Mahidol University (TH)
Good health and well-being
Natural Compound Pharmacology Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon